D-0552-2026 Class III Ongoing
FDA drug recall D-0552-2026 was initiated by Eugia US LLC on May 18, 2026 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan The recall status is ongoing. Affected quantity: 168,300 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 10, 2026
- Initiation Date
- May 18, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 168,300 vials
Product description
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Reason for recall
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Distribution pattern
US Nationwide.
Code information
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0552-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026